POSTER SESSION I STOWELL-ORBISON/AUTOPSY and SURGICAL PATHOLOGY AWARDS COMPETITION
Monday, March 9, 2009   9:30 AM - 12:00 Noon
Hynes Convention Center, Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
109
Novel Biomarkers Expression in Patients with Superficial and Minimally Invasive Urothelial Bladder Cancer and Their Assoaciation with Tumor Outcomes
(701)
L Ali, FR Herrmann, RT Cheney, P Mhawech-Fauceglia - Roswell Park Cancer Institiute, Buffalo, NY; University of Geneva, Geneva, Switzerland
Pathologic Features of Salvage Radical Prostatectomy Specimens Following Radiotherapy: Implications for Focal Therapeutic Options
(707)
L Andino, C Guo, E Chiong, IN Prokhorova, LL Pisters, P Troncoso - UT MD Anderson Cancer Center, Houston, TX
Renal Carcinomas Arising in Patients with Autosomal Dominant Polycystic Kidney Disease: A Clinicopathological Review
(710)
S Bai, O Hameed - University of Alabama School of Medicine, Birmingham, AL
Smoothelin Expression Is a Useful Adjunct for Assessing Muscularis Propria Invasion in Bladder Cancer
(720)
IM Bovio, SZ Al-Quran, PA Drew, RW Allan - University of Florida, Gainesville, FL
Primary Vascular Tumors of the Kidney: A Clinicopathologic Analysis of 26 Cases
(721)
JG Brown, MB Amin, P Rao, AJ Lazar, GP Paner, R Gupta, JC Cheville, AL Folpe - Cedars-Sinai Medical Center, Los Angeles, CA; MD Anderson Cancer Center, Houston, TX; Loyola University Medical Center, Maywood, IL; Mayo Clinic, Rochester, MN
P16 Expression Can Not Be Used To Differentiate between Squamous Cell Carcinomas of Uterine Cervix and Urinary Bladder
(731)
M Cioffi-Lavina, J Chapman-Fredricks, C Gomez-Fernandez, M Jorda - University of Miami Miller School of Medicine and UMSylvester Comprehensive Cancer Center, Miami, FL
Carbonic Anhydrase IX as a Novel Target for Cytological Detection and Therapy of Low Grade Urothelial Cell Carcinoma
(732)
JL Clebanoff, D Lung, M Noe, A Pantuck, P Fung, J Rao - University of California, Los Angeles, CA
Estrogen and Progesterone Receptor Positive Stroma in Pediatric Cystic Renal Dysplasia: An Immunohistochemical Study of 18 Cases
(735)
J Coviello-Malle, JK McKenney, A Heerema-McKenney - UAMS, Little Rock, AR; Stanford, Stanford, CA
Invasive Urothelial Carcinoma with Chordoid Features: A Clinicopathologic Study of 12 Cases
(736)
RM Cox, AG Schneider, AR Sangoi, WJ Clingan, N Gokden, JK McKenney - UAMS, Little Rock, AR; Stanford University, Stanford, CA
Primary Urethral Adenocarcinomas: A Clinicopathological Review
(740)
VL Dailey, PA Humphrey, O Hameed - University of Alabama at Birmingham, Birmingham, AL; Washington University School of Medicine, St. Louis, MO
Characterization of New Immunohistochemical Markers of Renal Angiomyolipoma
(752)
LJ Eisengart, AV Yeldandi, M Zhou, BT Teh, XJ Yang - Northwestern Memorial Hospital, Chicago, IL; Cleveland Clinic, Cleveland, OH; Van Andel Institute, Grand Rapids, MI
Prostatic Adenocarcinoma and Status of Resection Margin of Radical Prostatectomy Associated with Core Biopsies with Atypical Small Acinar Proliferation or Minimal Cancer
(761)
TA Flood, BN Nguyen, EC Marginean, BM Purgina, KT Mai - The Ottawa Hospital and The University of Ottawa, Ottawa, ON, Canada
Comprehensive Assessment of TMPRSS2 and ETS Family Molecular Aberrations in Histologic Variants of Prostate Carcinoma
(773)
B Han, R Mehra, N Palanisamy, K Suleman, M Zhou, AM Chinnaiyan, RB Shah - University of Michigan, Ann Arbor, MI; Cleveland Clinic, Cleveland, OH
Can Apical Prostatic Adenocarcinoma at Biopsy Stratify Patients for Ablative Therapies?
(778)
RC Heintzelman, X Chen, J Jaffe, FU Garcia - Drexel University College of Medicine, Philadelphia, PA
Differential Expression of Dicer in Oncocytomas, Papillary, Clear Cell and Chromophobe Renal Cell Carcinomas
(782)
S Hooda, M Acquafondata, R Dhir, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
Increased Lef1 Expression in Metastatic Prostate Cancer
(783)
H Huang, Y Li, J Melamed, P Lee, A de las Morenas - Boston University School of Medicine, Boston, MA; New York University School of Medicine, New York, NY
Nuclear Expression of SOX9 Protein as a Prognostic Marker in Invasive Bladder Urothelial Carcinomas: A Tissue Microarray Immunohistochemistry Study
(803)
TK Lee, R Albadine, S Jadallah, M Nielsen, SZ Ling, M Gonzalgo, DM Berman, GJ Netto - Johns Hopkins Hospital, Baltimore, MD
The Status of Positive Surgical Margin at Radical Prostatectomy and Risk of Biochemical Recurrence: A Single Institution Experience
(805)
M Li, J Song, S Shikanov, S Eggnener, A Shalhav, J Taxy, H Al-Ahmadie - University of Chicago, Chicago, IL
Insulin-Like Growth Factor Binding Protein 3 Is Up-Regulated in Prostatic Adenocarcinoma and Correlates with Gleason Grade
(808)
KD Linos, S Lu, JS Ross, TA Jennings, BM Mian, HAT Nazeer, CE Sheehan, T Nazeer - Albany Medical College, Albany, NY
Patients with Recurrent Prostate Adenocarcinoma Show Higher Levels of Somatostatin Receptor 2 Expression
(816)
NE Lueck, CM Simons, RD Williams, TM O'Dorisio, MS O'Dorisio, BR DeYoung - University of Iowa Hospitals and Clinics, Iowa City, IA
Assessment of Utility of TMPRSS2: ERG Gene Aberrations To Predict Salvage Radiotherapy Prostate Cancer Outcomes
(824)
R Mehra, B Han, RJ Lonigro, K Suleman, SA Tomlins, N Palanisamy, DA Hamstra, AM Chinnaiyan, RB Shah - University of Michigan, Ann Arbor, MI
TMPRSS2-ERG Gene Rearrangement Is Associated with C-MYC Protein Over-Expression in Prostate Cancer
(826)
R Merha, SA Tomlins, RJ Lonigo, L Wang, A Menon, RB Shah, AM Chinnaiyan - University of Michigan, Ann Arbor, MI
Small Cell Carcinoma of the Renal Pelvis and Ureter: Clinicopathologic and Immuno-histochemical Features
(832)
R Miller, SM Lele, S Holmang, S Johansson - University of Nebraska Medical Center, Omaha, NE; Sahlgrenska University Hospital, Goteborg, Sweden
Fluorescence In Situ Hybridization Assay for ERG Gene Disruption in Acinar (PCA-A) and Ductal (PCA-D) Subtypes of Prostatic Adenocarcinoma
(846)
LA Niemeier, K Cieply, R Dhir, AV Parwani, K Cumbie, C Sherer, J Salvatore, M Youschak, A Perepletchikov, G Cai, L Kiss, SI Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA
IFI16 Protein: A Potential Molecular Marker in Prostate Cancer: From Molecular Lab to the Pathology Lab
(863)
JP Reynolds, HX Bui, H Al-Ghawi, GA Hill, R Panchananthan, D Choubey - VAMC & U of Cincinnati, Cincinnati, OH
Renal Cancer in Tuberous Sclerosis: An Underdiagnosed Disease? Molecular, IHC and Pathologic Correlation
(866)
SR Chowdhuri, J Vicens, L Teller, WM Linehan, MJ Merino - National Cancer Institute, Bethesda, MD
Decreased Expression of CD38 in High Grade Prostate Cancer
(868)
JL Schmidt, AT Johnson (co-first author), SC Schmechel - University of Minnesota, Minneapolis, MN
Significant Inhibition of Tumor-Suppressor Genes in Renal Cell Carcinoma
(872)
SR Scrape, H Zhang, C Xie, N Gokden, CY Fan - University of Arkansas for Medical Sciences, Little Rock, AR; John L. McClellan Memorial Veterans Hospital, Little Rock, AR
The Value of Intraoperative Assessment of Pelvic Lymph Nodes during Radical Prostatectomy
(880)
J Song, J Taxy, H Al-Ahmadie - University of Chicago, Chicago, IL
Differential Expression of Heterochromatin Protein 1 in Renal Cortical Tumors
(897)
M Tretiakova, A Contreras, H Al-Ahmadie - University of Chicago, Chicago, IL
MicroRNA Expression Profiling Distinguishes Conventional and Chromophobe Renal Cell Carcinomas from Normal Renal Parenchyma
(928)
DL Zynger, WA LaFramboise, JM Krill-Burger, CM Sciulli, AM Hensler, AM Perepletchikov, LP Kiss, R Dhir, G Cai, AV Parwani, SI Bastacky - University of Pittsburgh Medical Center, Pittsburgh, PA